Korean J Ophthalmol.  2018 Dec;32(6):521-522. 10.3341/kjo.2018.0029.

Choroidal Osteoma Accompanied by Proliferative Diabetic Retinopathy

Affiliations
  • 1Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. sungpyo@hanafos.com

Abstract

No abstract available.


MeSH Terms

Choroid*
Diabetic Retinopathy*
Osteoma*

Figure

  • Fig. 1 (A) At fundus photography, yellowish elevated lesion with irregular margin was noted. (B) On fluorescein angiography, mild staining was observed for perifoveal area at late phase. (C) Highly reflective echo and posterior acoustic shadowing were observed in the ultrasonography. (D) Computed tomography showed mild infiltration at anterior ocular wall, asymmetrical swelling of lacrimal gland, and small calcif ication at posterior wall. (E) Computed tomography scan with bone density. (F) At initial examination, optical coherence tomography showed subretinal fluid with small choroidal neovascularization. (G) A month after intravitreal ranibizumab injection, subretinal fluid was completely absorbed.


Reference

1. Alameddine RM, Mansour AM, Kahtani E. Review of choroidal osteomas. Middle East Afr J Ophthalmol. 2014; 21:244–250.
Article
2. Shields CL, Sun H, Demirci H, Shields JA. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol. 2005; 123:1658–1666.
Article
3. Najafabadi FF, Hendimarjan SM, Zarrin Y, Najafabadi MF. Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization. J Ophthalmic Vis Res. 2015; 10:484–486.
Article
4. Pandey N, Guruprasad A. Choroidal osteoma with choroidal neovascular membrane: successful treatment with intravitreal bevacizumab. Clin Ophthalmol. 2010; 4:1081–1084.
Article
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr